5) Intrinsic enzymatic activity which makes it possible to design ligand-targeted drugs 6) Receptor-mediated Endocytosis of PSMA-targeted ligands leads to ligand retention into tumor cells. The gene discussed is FOLH1; the disease is neoplasm.